Listen to the article
The U.S. Department of Health and Human Services unveiled a new strategy Thursday that aims to significantly expand its use of artificial intelligence across the agency, highlighting the Trump administration’s embrace of emerging technologies while raising concerns about data privacy and protection.
The 20-page document, described as a “first step,” primarily focuses on improving operational efficiency and coordinating AI implementation across HHS divisions. However, it also hints at more ambitious plans to leverage AI for analyzing patient health data and accelerating drug development processes.
“For too long, our Department has been bogged down by bureaucracy and busy-work,” wrote Deputy HHS Secretary Jim O’Neill in the strategy’s introduction. “It is time to tear down these barriers to progress and unite in our use of technology to Make America Healthy Again.”
The initiative reflects the broader Trump administration approach to artificial intelligence, which has encouraged federal employees to adopt chatbots and AI assistants for daily tasks. Earlier this year, HHS made ChatGPT available to all department employees. This marks a significant policy shift from the Biden administration, which had established guardrails for AI use through an executive order that President Trump subsequently repealed upon taking office.
The strategy outlines five key pillars: creating a risk management governance structure, designing AI resources for department-wide use, empowering employees with AI tools, funding programs to establish standards for AI in research, and incorporating AI in public health and patient care.
Some HHS divisions are already working on AI systems that could “deliver personalized, context-aware health guidance to patients by securely accessing and interpreting their medical records in real time,” according to the document.
The department projects a 70% increase in AI implementations for the 2025 fiscal year, building on the 271 active or planned AI projects already underway in 2024.
However, experts have raised concerns about the administration’s approach, particularly given HHS’s access to sensitive health information. The department previously faced scrutiny for sharing Medicaid recipients’ personal health data with Immigration and Customs Enforcement officials, pushing the boundaries of legal data sharing.
Oren Etzioni, an AI expert who founded a nonprofit combating political deepfakes, cautioned that while HHS’s enthusiasm for AI in healthcare deserves recognition, safety should not be compromised for speed.
“The HHS strategy lays out ambitious goals — centralized data infrastructure, rapid deployment of AI tools, and an AI-enabled workforce — but ambition brings risk when dealing with the most sensitive data Americans have: their health information,” Etzioni said.
He acknowledged positive elements in the strategy, such as calls for scientific rigor, risk assessments, and transparency in AI development. However, Etzioni expressed doubts about whether these standards could be met under Health Secretary Robert F. Kennedy Jr., whom he criticized for previously disregarding scientific principles.
Some members of Kennedy’s own “Make America Healthy Again” movement have expressed reservations about technology companies gaining access to personal health information through these initiatives.
Darrell West, senior fellow at the Brookings Institution’s Center for Technology Innovation, noted that while the strategy promises strengthened risk management, it lacks detailed information about implementation.
“There are a lot of unanswered questions about how sensitive medical information will be handled and the way data will be shared,” West said. “There are clear safeguards in place for individual records, but not as many protections for aggregated information being analyzed by AI tools.”
Despite these concerns, West remains optimistic about the potential benefits if implemented properly. “This could become a transformative example of a modernized agency that performs at a much higher level than before,” he said.
As HHS moves forward with its AI strategy, the balance between technological advancement and data protection will likely remain a critical focus for both supporters and critics of the initiative, particularly as the department handles some of the most sensitive personal information in the federal government’s possession.
Fact Checker
Verify the accuracy of this article using The Disinformation Commission analysis and real-time sources.
8 Comments
Tearing down bureaucratic barriers to progress through AI adoption is an admirable goal, but the agency should proceed cautiously and engage with all stakeholders to get the implementation right.
The Trump administration’s push for federal agencies to embrace AI is a significant policy shift. It will be important to ensure the right safeguards are in place as AI is increasingly used in healthcare.
The “Make America Healthy Again” vision is ambitious. AI could be a powerful tool, but HHS will need to balance innovation with robust data governance to maintain public trust.
Leveraging AI for analyzing patient data and drug development sounds promising, but HHS will have to navigate complex ethical and regulatory issues around data privacy. Transparency will be key.
Making AI tools like ChatGPT available to all HHS employees could boost productivity, but the agency will need to provide robust training and guidelines to mitigate potential risks or misuse.
I’m curious to see how this AI strategy will evolve and what specific use cases emerge within HHS. Effective coordination across divisions will be crucial for realizing the full benefits.
Interesting to see HHS taking a proactive approach to adopting AI technology. Improving operational efficiency and accelerating drug development could have major benefits, but data privacy and protection will be crucial.
As with any emerging technology, there will be challenges and risks to navigate. I hope HHS takes a measured, ethical approach that prioritizes patient privacy and safety.